Q4 & FY22 Highlights slide image

Q4 & FY22 Highlights

In-house adoption of Digital Histopathology Reporting of Digital Breast cancer Panels using Al based algorithms Digital Histopathology for remote routine reporting Opportunities created by Digital Histopathology • Enhanced access to second opinion, synchronous review of slides • Enhanced quality of reporting • Potential for insourcing services • Leveraging Artificial Intelligence for Histopathology • Potential for de-centralization of histopathology reporting Classification: Restricted 40 Dr Lal PathLabs
View entire presentation